DexCom outlines 2026 revenue growth of 11%-13% with G7 15 Day rollout and international expansion (NASDAQ:DXCM)
德康医疗德康医疗(US:DXCM) Seeking Alpha·2026-02-13 09:06

技术访问问题 - 用户需在浏览器中启用Javascript和cookies以确保未来正常访问 [1] - 启用广告拦截器可能导致访问受阻，用户需禁用该功能并刷新页面 [1]

DexCom outlines 2026 revenue growth of 11%-13% with G7 15 Day rollout and international expansion (NASDAQ:DXCM) - Reportify